Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JMM who wrote (5139)	8/13/1998 4:37:00 PM
From: sam	of 6136

OTOTOTOT <<It's ironic that its a disease that people want to control and have less of... but some companies have it as a growth vehicle for profits.>> Yea -- shame on Merck and AGPH for wanting to give AIDs patients some quality of life. And shame on me for being an AGPH profiteer. What I find potentially "ironic" is that there are people shorting the heck out of companies doing cancer research. And, by shorting those companies, those "investors" actually make it harder for the companies to do research (i.e. leveraging their stock for purposes of...say...enticing researchers or keeping them inhouse with options packages). The "irony," of course, would be if any of those "investors" actually get cancer themselves. BTW, what disease do people want MORE of?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next